Vault-13

SAMSARA BIOCAPITAL, LLC

PALO ALTO, CA · CIK 1744967 · 13F filing filed 2025-08-14

SEC-registered investment adviser since 2018 · limited liability company

As an employer

US visa salary filings

Job titleFilingsMedianRange
Senior AssociatePalo Alto, CA 2 $187,500 $175,000 – $200,000

Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Samsara BioCapital, LLC.

$488.9m reported value -12.8% vs Q1 2025
29positions
88.2%in top 10
3 new 1 added 8 reduced 11 sold out vs Q1 2025

Holdings, Q2 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 5,612,896 $198.8m40.66% 40.66% UnchangedShares held: Q3 2024 6.8m, Q4 2024 5.6m, Q1 2025 5.6m, Q2 2025 5.6m
2 MINERALYS THERAPEUTICS INC COM MLYS MLYS 5,674,916 $76.8m15.70% 15.70% UnchangedShares held: Q3 2024 5.1m, Q4 2024 5.1m, Q1 2025 5.7m, Q2 2025 5.7m
3 SEPTERNA INC COM SEPN SEPN 3,149,128 $33.3m6.81% 6.81% UnchangedShares held: Q3 2024 0, Q4 2024 2.8m, Q1 2025 3.1m, Q2 2025 3.1m
4 KALARIS THERAPEUTICS INC COM KLRS KLRS 11,448,081 $30.6m6.25% 6.25% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 11.4m, Q2 2025 11.4m
5 NEUROGENE INC COM NGNE NGNE 1,717,127 $25.7m5.25% 5.25% UnchangedShares held: Q3 2024 1.3m, Q4 2024 1.7m, Q1 2025 1.7m, Q2 2025 1.7m
6 CARGO THERAPEUTICS INC COM COM 4,415,689 $18.2m3.72% 3.72% UnchangedShares held: Q3 2024 4.4m, Q4 2024 4.4m, Q1 2025 4.4m, Q2 2025 4.4m
7 UPSTREAM BIO INC COM UPB UPB 1,443,231 $15.8m3.24% 3.24% ReducedShares held: Q3 2024 0, Q4 2024 2.2m, Q1 2025 2.1m, Q2 2025 1.4m -623.9k -623,915 -30.2%
8 ALUMIS INC COM ALMS ALMS 4,801,370 $14.4m2.95% 2.95% AddedShares held: Q3 2024 3.3m, Q4 2024 3.3m, Q1 2025 3.3m, Q2 2025 4.8m +1.5m +1,534,872 47.0%
9 LENZ THERAPEUTICS INC COM LENZ LENZ 343,012 $10.1m2.06% 2.06% ReducedShares held: Q3 2024 1.2m, Q4 2024 987.0k, Q1 2025 526.4k, Q2 2025 343.0k -183.4k -183,378 -34.8%
10 PALVELLA THERAPEUTICS INC NE COM PVLA PVLA 339,743 $7.7m1.57% 1.57% ReducedShares held: Q3 2024 0, Q4 2024 679.5k, Q1 2025 679.5k, Q2 2025 339.7k -339.7k -339,743 -50.0%
11 GOSSAMER BIO INC COM GOSS GOSS 6,130,268 $7.5m1.54% 1.54% UnchangedShares held: Q3 2024 6.1m, Q4 2024 6.1m, Q1 2025 6.1m, Q2 2025 6.1m
12 ARCELLX INC COMMON STOCK ACLX ACLX 101,457 $6.7m1.37% 1.37% ReducedShares held: Q3 2024 353.6k, Q4 2024 253.6k, Q1 2025 135.3k, Q2 2025 101.5k -33.8k -33,819 -25.0%
13 AURA BIOSCIENCES INC COM AURA AURA 1,000,000 $6.3m1.28% 1.28% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 1.0m
14 NKARTA INC COM NKTX NKTX 3,768,035 $6.3m1.28% 1.28% UnchangedShares held: Q3 2024 3.8m, Q4 2024 3.8m, Q1 2025 3.8m, Q2 2025 3.8m
15 AVADEL PHARMACEUTICALS PLC COM SHS AVDL AVDL 675,504 $6.0m1.22% 1.22% ReducedShares held: Q3 2024 967.5k, Q4 2024 967.5k, Q1 2025 967.5k, Q2 2025 675.5k -292.0k -292,023 -30.2%
16 JADE BIOSCIENCES INC COM NEW JBIO JBIO 531,163 $5.3m1.09% 1.09% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 531.2k
17 ZYMEWORKS INC COM ZYME ZYME 310,300 $3.9m0.80% 0.80% ReducedShares held: Q3 2024 1.0m, Q4 2024 1.0m, Q1 2025 666.7k, Q2 2025 310.3k -356.4k -356,367 -53.5%
18 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 50,476 $3.2m0.65% 0.65% ReducedShares held: Q3 2024 172.6k, Q4 2024 172.6k, Q1 2025 138.1k, Q2 2025 50.5k -87.6k -87,642 -63.5%
19 VTV THERAPEUTICS INC CL A NEW VTVT VTVT 206,784 $3.1m0.63% 0.63% UnchangedShares held: Q3 2024 206.8k, Q4 2024 206.8k, Q1 2025 206.8k, Q2 2025 206.8k
20 CONTINEUM THERAPEUTICS INC CL A CTNM CTNM 588,816 $2.3m0.48% 0.48% UnchangedShares held: Q3 2024 588.8k, Q4 2024 588.8k, Q1 2025 588.8k, Q2 2025 588.8k
21 SURROZEN INC COM NEW SRZN SRZN 241,400 $2.2m0.44% 0.44% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 241.4k, Q2 2025 241.4k
22 SUTRO BIOPHARMA INC COM COM 2,196,814 $1.6m0.32% 0.32% UnchangedShares held: Q3 2024 2.2m, Q4 2024 2.2m, Q1 2025 2.2m, Q2 2025 2.2m
23 TANGO THERAPEUTICS INC COM TNGX TNGX 210,000 $1.1m0.22% 0.22% ReducedShares held: Q3 2024 630.0k, Q4 2024 630.0k, Q1 2025 630.0k, Q2 2025 210.0k -420.0k -420,000 -66.7%
24 HILLEVAX INC COM COM 399,637 $795.3k0.16% 0.16% UnchangedShares held: Q3 2024 799.3k, Q4 2024 399.6k, Q1 2025 399.6k, Q2 2025 399.6k
25 TERNS PHARMACEUTICALS INC COM COM 202,348 $754.8k0.15% 0.15% UnchangedShares held: Q3 2024 202.3k, Q4 2024 202.3k, Q1 2025 202.3k, Q2 2025 202.3k
26 ARTIVA BIOTHERAPEUTICS INC COM ARTV ARTV 291,666 $440.4k0.09% 0.09% UnchangedShares held: Q3 2024 291.7k, Q4 2024 291.7k, Q1 2025 291.7k, Q2 2025 291.7k
27 BOLT BIOTHERAPEUTICS INC COM NEW BOLT BOLT 52,456 $302.7k0.06% 0.06% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 52.5k
28 NUVATION BIO INC *W EXP 07/07/202 NUVB.WS NUVB.WS 133,333 $36.0k0.01% 0.01% UnchangedShares held: Q3 2024 133.3k, Q4 2024 133.3k, Q1 2025 133.3k, Q2 2025 133.3k
29 SURROZEN INC *W EXP 08/01/203 *W EXP 08/01/203 99,999 $1.8k0.00% 0.00% UnchangedShares held: Q3 2024 100.0k, Q4 2024 100.0k, Q1 2025 100.0k, Q2 2025 100.0k

Sold out since Q1 2025

SecurityTickerShares held beforeValue then
ACELYRIN INC 2,523,022 $6.2m2.5m shares
ONKURE THERAPEUTICS INC OKUR OKUR 824,155 $3.5m824.2k shares
ABIVAX SA ABVX ABVX 425,000 $2.7m425.0k shares
INOZYME PHARMA INC 1,562,500 $1.4m1.6m shares
PRIME MEDICINE INC PRME PRME 405,228 $806.4k405.2k shares
LEAP THERAPEUTICS INC CYPH CYPH 2,442,352 $745.2k2.4m shares
BOLT BIOTHERAPEUTICS INC 1,049,153 $419.7k1.0m shares
CURIS INC 185,943 $390.5k185.9k shares
LYRA THERAPEUTICS INC LYRA LYRA 1,390,130 $175.6k1.4m shares
KRONOS BIO INC KRON KRON 78,131 $64.5k78.1k shares
ALLAKOS INC ALLKG ALLKG 172,089 $39.2k172.1k shares